Company news

MediPharm Labs Corp. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

MediPharm Labs Files Proxy Materials, Issues Chair's Letter to Shareholders

May 12, 2025

MediPharm Labs Sets Date to Report First Quarter 2025 Financial Results

May 9, 2025

MediPharm Labs Responds to Dissident Shareholder's Filing

May 8, 2025

Apollo Technology Capital Corporation to Nominate Six Highly Qualified Directors to MediPharm Labs' Board of Directors Following Years of Shareholder Value Destruction

May 8, 2025

MediPharm Labs Reports Full Year & Fourth Quarter 2024 Results

March 31, 2025

MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2024 Financial Results

March 26, 2025

MediPharm Labs Announces Termination of the Proposed Sale of Napanee Facility to Kensana Health

February 10, 2025

MediPharm Labs Provides Update on Previously Announced Sale of Napanee Facility to Kensana Health

January 16, 2025

MediPharm Labs Enters Landmark Commercial Agreement with Laboratório Teuto in Brazil

January 8, 2025

MediPharm Labs to Sell its Napanee Facility to Kensana Health for $5.5M

December 17, 2024

MediPharm Labs Reports Third Quarter Results

November 14, 2024

MediPharm Labs Sets Date to Report Third Quarter 2024 Financial Results

November 11, 2024

MediPharm Labs Announces Departure of President and Co-Founder Keith Strachan

October 17, 2024

MediPharm Labs Announces $2.1M Debt Repayment

September 17, 2024

MediPharm Labs Reports Second Quarter Results Closing in on Positive Adjusted EBITDA(1) as Gross Profit Continues to Improve

August 14, 2024

MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results

August 13, 2024

MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results

August 8, 2024

MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of Shareholders

June 26, 2024

MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose Aerosols

June 20, 2024

MediPharm Labs Reports First Quarter Results

May 15, 2024

MediPharm Labs Sets Date to Report First Quarter 2024 Financial Results

May 8, 2024

MediPharm Labs Provides Conference Call Recording Details

March 27, 2024

MediPharm Labs Reports Fourth Quarter and Full Year Results

March 27, 2024

MediPharm Labs Provides Update on German Cannabis Legalization

March 25, 2024

MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial Results

March 22, 2024

MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health Authority

February 7, 2024

MediPharm Labs Provides Update on Board of Directors and Long Term Incentive Program

December 22, 2023

MediPharm Labs Sets Date to Report Third Quarter 2023 Financial Results

November 8, 2023

MediPharm Labs Update on $9M Settlement Agreement - All Tilray Shares Sold and Converted to Cash

October 25, 2023

MediPharm Labs Settles an Outstanding Claim for $9M

October 2, 2023

MediPharm Labs Launches new GMP Products to the Australian Medical Cannabis Market

September 27, 2023

MediPharm Labs Improves Domestic Sales Gross Margin with Termination of Shelter Cannabis Brands Royalty Agreement

September 20, 2023

MediPharm Labs Completes Sale of Vacant Land for Cash Proceeds of $1.9 million

September 5, 2023

MediPharm Labs Publishes Study Investigating Medical Cannabis Impacts on Anxiety and Depression Outcomes in Fibromyalgia Patients

August 31, 2023

MediPharm Labs Reports Second Quarter Results with Doubling of Revenue and Record Margin Growth

August 14, 2023

MediPharm Labs Sets Date to Report Second Quarter 2023 Financial Results

August 10, 2023

MediPharm Labs Makes First Delivery of Cannabis Clinical Trial Material to US Research Partner and Provides Update on US FDA Status

August 1, 2023

MediPharm Labs Announces Change of Auditor

June 22, 2023

MediPharm Labs Reports First Quarter Results with Growth in Sales, Margin and EBITDA

May 15, 2023

MediPharm Labs Sets Date to Report First Quarter 2023 Financial Results

May 10, 2023

MediPharm Labs Provides Update on VIVO Integration and Board Appointee

April 13, 2023

MediPharm Labs Corp. Completes Acquisition of VIVO Cannabis Inc. and Confirms Final Ownership Ratio

April 3, 2023

MediPharm Labs Reports Fourth Quarter and Full Year 2022 Results

March 31, 2023

MediPharm Labs Sets Date to Report Fourth Quarter and Full Year 2022 Financial Results

March 28, 2023

MediPharm Labs Corp. Announces Voting Results From Special Meeting of Shareholders

March 21, 2023

MediPharm Labs Provides Update on Clinical Trial Progress Including FDA Approval of Partner Study

March 1, 2023

MediPharm Labs Corp. Announces Mailing and Filing of Joint Circular for Special Meeting of Shareholders to approve Arrangement with VIVO Cannabis Inc.

February 21, 2023

MediPharm Labs Corp. to Acquire VIVO Cannabis Inc.

December 22, 2022

MediPharm Labs Receives Award for CBD Brand of the Year

December 8, 2022

MediPharm Labs Sets Date to Report Third Quarter 2022 Financial Results

November 9, 2022

← Newer news releases · Older news releases →

Calls

The 5 newest of 19 calls. Every call is listed under its year.

Decks

The 5 newest of 6 decks. Every deck is listed under its year.